Sheila DeWitt
Fortune : 12 227 $ au 31/07/2026
Fortune : 12 227 $ au 31/07/2026
Sheila DeWitt is the founder of Deuterx LLC, founded in 2012, holding the titles of Chairman, President & Chief Executive Officer.
Dr. DeWitt is also the founder of Diversomer Technologies, Inc...
Dr. DeWitt currently serves as Director at Riffit, Inc., Chief Operating Officer & Director at Neuromity Therapeutics, Inc., and Independent Director at Enveric Biosciences, Inc. since 2024.
Former positions include Chairman, President & Chief Executive Officer at Deuteria Pharmaceuticals, Inc. from 2010 to 2012, Vice President-Portfolio Development at ArQule, Inc., Vice President-Discovery at EPIX Pharmaceuticals, Inc. from 2005 to 2009, and Business Unit Head at Orchid Cellmark, Inc. Education includes a doctorate from Duke University conferred in 1986 and an undergraduate degree from Cornell University conferred in 1982.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/06/2026 | 7 788 ( 0,17 % ) | 12 227 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ENVERIC BIOSCIENCES, INC. | Directeur/Membre du Conseil | 01/05/2024 |
Deuterx LLC
Deuterx LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company provides drugs for patients | Directeur Général | 01/01/2012 |
Riffit, Inc.
Riffit, Inc. Medical/Nursing ServicesHealth Services Provides musical therapy solutions | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
Deuteria Pharmaceuticals, Inc.
Deuteria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | 01/12/2012 |
Diversomer Technologies, Inc. | Fondateur | - |
| ARQULE, INC. | Corporate Officer/Principal | - |
Orchid Cellmark, Inc.
Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Provides DNA testing services | Corporate Officer/Principal | - |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
ArQule, Inc.
ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | Health Technology |
Orchid Cellmark, Inc.
Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Provides DNA testing services | Commercial Services |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Diversomer Technologies, Inc. | |
Deuterx LLC
Deuterx LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company provides drugs for patients | Health Technology |
Deuteria Pharmaceuticals, Inc.
Deuteria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Enveric Biosciences, Inc.
Enveric Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Develops cannabinoid medicines and combination therapies | Health Technology |
Riffit, Inc.
Riffit, Inc. Medical/Nursing ServicesHealth Services Provides musical therapy solutions | Health Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national